GO:0001953 negative regulation of cell-matrix adhesion: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001953 (negative regulation of cell-matrix adhesion) describes any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
• The process is controlled by a balance of positive and negative regulators, including Rho-family GTPases, integrin-linked kinase (ILK), focal adhesion kinase (FAK), paxillin, and matrix metalloproteinases (MMPs) with their inhibitors (TIMPs).
• Negative regulation of cell-matrix adhesion is essential for normal development, tissue homeostasis, and wound healing, and its dysregulation contributes to cancer invasion, metastasis, and fibrosis.
• Key experimental approaches include knockout and point-mutation cell models, live-cell imaging of focal adhesions, and biochemical assays of adhesion turnover.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in this pathway.
• Understanding this process supports drug discovery targeting adhesion-dependent diseases, including cancer and inflammatory disorders.
Description
Cell-matrix adhesion is the physical attachment of cells to the extracellular matrix (ECM), a process critical for tissue architecture, migration, and signaling. The Gene Ontology term GO:0001953, negative regulation of cell-matrix adhesion, refers to any process that stops, prevents, or reduces the rate or extent of this adhesion. This regulatory mechanism is essential for dynamic cellular behaviors such as detachment during migration, tissue remodeling, and the resolution of wound healing. Dysregulation of cell-matrix adhesion is a hallmark of cancer progression, where increased adhesion can promote invasion and metastasis, while excessive negative regulation may impair tissue integrity. Researchers study this process to understand fundamental cell biology and to identify therapeutic targets for diseases ranging from cancer to fibrosis. The interplay between adhesion complexes and signaling molecules like Rho GTPases, integrin-linked kinase (ILK), and focal adhesion kinase (FAK) provides a rich area for investigation.
negative regulation of cell-matrix adhesion At A Glance
| GO ID | GO:0001953 |
|---|---|
| GO term | negative regulation of cell-matrix adhesion |
| Ontology | biological_process |
| Synonym | down regulation of cell-matrix adhesion, down-regulation of cell-matrix adhesion, downregulation of cell-matrix adhesion, inhibition of cell-matrix adhesion |
| Major function | Reduces the rate or extent of cell adhesion to the extracellular matrix |
| Related processes | Cell migration, focal adhesion disassembly, cytoskeletal reorganization, signal transduction |
| Key regulators | Rho GTPases, ILK, FAK, paxillin, MMPs, TIMPs |
| Disease relevance | Cancer invasion and metastasis, fibrosis, inflammatory disorders |
What Is GO:0001953?
GO:0001953 is defined as any biological process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix. It encompasses molecular events that weaken or disassemble integrin-mediated adhesions, modulate cytoskeletal tension, or alter the expression and activity of adhesion components, ultimately leading to decreased cell-ECM attachment.
Why Is negative regulation of cell-matrix adhesion Important in Cell Biology?
Negative regulation of cell-matrix adhesion is fundamental to dynamic cellular processes such as migration, differentiation, and tissue remodeling. It ensures that cells can detach from the ECM when necessary, for example during embryonic development or immune cell trafficking. In cancer, loss of this negative regulation can lead to increased adhesion and metastasis, while excessive negative regulation may contribute to tissue breakdown. Understanding the molecular players, including Rho GTPases, ILK, and MMPs, provides opportunities for therapeutic intervention.
• Controls cell migration and invasion, critical for development and immune responses.
• Dysregulation is linked to cancer metastasis and poor prognosis.
• Involved in tissue remodeling and wound healing.
• Modulates signaling pathways such as STAT1 and integrin signaling.
• Provides targets for anti-cancer and anti-fibrotic therapies.
• Essential for maintaining tissue homeostasis and preventing aberrant adhesion.
• Interacts with cell-cell adhesion systems to coordinate collective cell behavior.
• Regulated by mechanical forces and cytoskeletal tension.
• MMPs and TIMPs are key effectors in tumor cell adhesion.
• Experimental models using CRISPR enable precise dissection of gene function.
What Happens During negative regulation of cell-matrix adhesion?
Initiation by signaling cues
In simple terms: Cells receive signals that tell them to let go of the matrix.
Negative regulation of cell-matrix adhesion is initiated by extracellular or intracellular signals, such as growth factors, cytokines, or mechanical cues, that activate specific signaling pathways. Rho-family GTPases, including RhoA and Rac1, are central mediators that can either promote or inhibit adhesion depending on context. For example, RhoA activity can increase cytoskeletal tension and lead to focal adhesion maturation, while its downregulation or inhibition can promote disassembly. Integrin-linked kinase (ILK) also regulates adhesion dynamics by modulating Rac-1 activity.
Disassembly of focal adhesions
In simple terms: The sticky patches that attach the cell to the matrix are taken apart.
Focal adhesions are multi-protein complexes that link integrins to the actin cytoskeleton. Negative regulation involves the disassembly of these complexes through phosphorylation and proteolysis of key components such as paxillin and focal adhesion kinase (FAK). Paxillin interactions are critical for focal adhesion turnover, and its modification can lead to adhesion disassembly. FAK, a tyrosine kinase, is a central regulator of focal adhesion dynamics, and its inhibition or degradation promotes detachment.
Proteolytic remodeling of the ECM
In simple terms: Enzymes cut the matrix to weaken the attachment.
Matrix metalloproteinases (MMPs) can degrade ECM components, thereby reducing the availability of ligands for integrins and promoting detachment. Conversely, tissue inhibitors of metalloproteinases (TIMPs) negatively regulate MMP activity, thus modulating adhesion. The balance between MMPs and TIMPs is a key determinant of cell-matrix adhesion strength and is often disrupted in cancer.
Cytoskeletal reorganization and tension modulation
In simple terms: The cell's internal skeleton changes to pull away from the matrix.
Actin cytoskeleton reorganization is essential for adhesion disassembly. RhoA and Src kinases selectively regulate cytoskeletal tension and cell-matrix adhesion, with RhoA promoting contractility and Src modulating adhesion turnover. OLA1, an Obg-like ATPase, has been shown to regulate cell-matrix adhesion, possibly through effects on cytoskeletal dynamics. These changes reduce the mechanical coupling between the cell and the ECM, leading to detachment.
Integration with cell-cell adhesion and signaling
In simple terms: The process is coordinated with other adhesion systems and signaling pathways.
Negative regulation of cell-matrix adhesion is often coordinated with cell-cell adhesion. For instance, cell adhesion and cell density can negatively regulate interferon-γ/STAT1 signaling through STAT1 dephosphorylation, linking adhesion status to cytokine signaling. This crosstalk ensures that cells integrate multiple adhesion inputs to make decisions about migration, proliferation, and survival.
Key Genes Involved in GO:0001953 negative regulation of cell-matrix adhesion
The following genes and proteins are key players in the negative regulation of cell-matrix adhesion, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RhoA | Regulates cytoskeletal tension and focal adhesion dynamics | Key mediator of adhesion turnover; target for cancer and fibrosis studies |
| Rac1 | Modulates adhesion dynamics downstream of ILK | Involved in migration and invasion; studied in knockout models |
| ILK | Integrin-linked kinase; regulates Rac-1 and adhesion turnover | Central node in adhesion signaling; knockout and point mutants available |
| FAK | Focal adhesion kinase; regulates focal adhesion disassembly | Major regulator; target for cancer therapeutics |
| Paxillin | Scaffold protein in focal adhesions; interacts with FAK and others | Critical for adhesion assembly and disassembly; studied via mutagenesis |
| OLA1 | Obg-like ATPase 1; regulates cell-matrix adhesion | Novel regulator; knockout models show adhesion defects |
| MMP2 | Degrades ECM components, reducing adhesion | Implicated in cancer invasion; balance with TIMPs is key |
| MMP9 | Degrades ECM, promotes detachment | Associated with metastasis; therapeutic target |
| TIMP1 | Inhibits MMPs, thereby stabilizing adhesion | Modulates MMP activity; affects tumor cell adhesion |
| TIMP2 | Inhibits MMPs, stabilizes ECM | Regulates adhesion indirectly; studied in cancer models |
| Src | Tyrosine kinase; modulates adhesion turnover | Selectively regulates cytoskeletal tension and adhesion |
| STAT1 | Transcription factor; dephosphorylated upon adhesion | Links adhesion to cytokine signaling |
| Integrin β1 | Major ECM receptor; adhesion strength | Target for knockout and knock-in studies |
| Integrin α5 | Fibronectin receptor; adhesion | Modeled in adhesion research |
| Actin (ACTB) | Cytoskeletal component; tension generation | Essential for adhesion dynamics |
| Vinculin | Focal adhesion protein; links integrins to actin | Marker of adhesion sites; studied in KO models |
| Talin | Activates integrins and links to actin | Key for adhesion assembly; knockout lethal |
| Kindlin | Integrin activator; focal adhesion component | Regulates adhesion strength; disease-linked |
How Is negative regulation of cell-matrix adhesion Regulated?
The negative regulation of cell-matrix adhesion is itself tightly regulated by multiple mechanisms. Rho-family GTPases act as molecular switches, with their activity controlled by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). ILK and FAK are kinases that phosphorylate downstream targets to modulate adhesion turnover. MMPs and TIMPs provide proteolytic control of ECM ligands. Additionally, cell density and cell-cell adhesion can influence cell-matrix adhesion through signaling pathways such as STAT1. Mechanical forces also feed back to regulate adhesion strength and disassembly.
negative regulation of cell-matrix adhesion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAK | Cancer invasion and metastasis | Knockout and point-mutation cell lines; xenograft models |
| ILK | Cancer, fibrosis | Knockout and overexpression models; conditional KO mice |
| MMP9 | Cancer metastasis, inflammation | Knockout mice; CRISPR KO in cancer cell lines |
| RhoA | Cancer, fibrosis | Point-mutation (constitutively active) knock-in models |
| STAT1 | Inflammatory signaling | Knockout and phospho-mutant knock-in |
Cancer invasion and metastasis
Dysregulated negative regulation of cell-matrix adhesion contributes to cancer progression. Increased adhesion can promote invasion, while loss of negative regulation may lead to metastasis. MMPs and TIMPs are frequently imbalanced in tumors, and high MMP activity correlates with poor prognosis. FAK and ILK are overexpressed in many cancers and are targets for therapeutic intervention.
Fibrotic diseases
Excessive cell-matrix adhesion and reduced negative regulation can lead to fibrosis, characterized by excessive ECM deposition. Modulating adhesion pathways, such as those involving RhoA and ILK, may offer therapeutic strategies.
Inflammatory and immune disorders
Cell-matrix adhesion is critical for immune cell trafficking. Negative regulation allows immune cells to detach and migrate to sites of inflammation. Dysregulation can contribute to chronic inflammation and autoimmune diseases.
From negative regulation of cell-matrix adhesion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate cell-matrix adhesion? | CRISPR knockout cell line; adhesion assays |
| What is the effect of a specific phosphorylation site? | Point-mutation knock-in (e.g., phospho-deficient) |
| How does a disease-associated mutation affect adhesion? | Knock-in of mutant allele; live-cell imaging |
| Where and when is the protein expressed? | Tagged knock-in (e.g., GFP) for imaging |
| Does overexpression alter adhesion dynamics? | Overexpression cell line; adhesion turnover assays |
| Can we identify novel regulators? | CRISPR library screening; bioinformatics |
How to Study the negative regulation of cell-matrix adhesion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Adhesion assay | Number of attached cells | Quantify cell-matrix adhesion strength |
| Live-cell imaging | Focal adhesion dynamics | Visualize assembly/disassembly in real time |
| Western blot | Protein phosphorylation and expression | Assess signaling changes |
| Immunoprecipitation | Protein-protein interactions | Identify complexes at adhesions |
| Proteomics | Global protein changes | Discover novel regulators |
| CRISPR screening | Gene function in adhesion | Identify hits that regulate adhesion |
| Traction force microscopy | Cellular traction forces | Measure mechanical tension |
| MMP activity assay | Proteolytic activity | Assess ECM degradation |
Adhesion assays
Cell-matrix adhesion can be measured using adhesion assays, such as plating cells on ECM-coated surfaces and quantifying attached cells after washing. This provides a direct readout of adhesion strength and can be used to assess the effects of gene knockout or overexpression.
Live-cell imaging of focal adhesions
Fluorescently tagged focal adhesion proteins (e.g., paxillin-GFP) allow real-time visualization of adhesion assembly and disassembly. This method reveals dynamics and can be combined with knockout or knock-in models to study specific genes.
Biochemical analysis of signaling
Western blotting and immunoprecipitation can assess phosphorylation states of key regulators like FAK, ILK, and STAT1. These techniques help elucidate signaling pathways that negatively regulate adhesion.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify protein complexes and post-translational modifications in adhesion sites. This approach can uncover novel regulators and crosstalk.
How CRISPR Can Be Used to Study GO:0001953 negative regulation of cell-matrix adhesion
Knockout
CRISPR knockout of candidate genes (e.g., ILK, FAK, OLA1) allows researchers to determine whether the gene is required for negative regulation of cell-matrix adhesion. Knockout cell lines can be subjected to adhesion assays and imaging to quantify changes.
Point Mutation
Point mutations can be introduced to study specific phosphorylation sites or catalytic residues. For example, phospho-deficient mutants of FAK or paxillin can reveal the importance of specific modifications in adhesion turnover.
Knock-in
Knock-in of tagged proteins (e.g., GFP-paxillin) enables live-cell imaging of focal adhesions. Disease-associated mutations can also be knocked in to model their effects on adhesion.
Overexpression
Overexpression of negative regulators (e.g., TIMPs, dominant-negative RhoA) can enhance adhesion disassembly. This approach is useful for gain-of-function studies and for validating therapeutic targets.
How EDITGENE Supports negative regulation of cell-matrix adhesion Research
Researchers studying negative regulation of cell-matrix adhesion-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cell-matrix adhesion research.
Frequently Asked Questions About negative regulation of cell-matrix adhesion
What is GO:0001953?
GO:0001953 is the Gene Ontology term for negative regulation of cell-matrix adhesion, defined as any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
What genes are involved in negative regulation of cell-matrix adhesion?
Key genes include RhoA, Rac1, ILK, FAK, paxillin, OLA1, MMPs, TIMPs, and STAT1.
How is cell-matrix adhesion negatively regulated?
It is regulated through signaling pathways involving Rho GTPases, kinases like ILK and FAK, proteolytic remodeling by MMPs, and cytoskeletal reorganization.
Why is negative regulation of cell-matrix adhesion important in cancer?
Dysregulation can lead to increased invasion and metastasis; MMPs and FAK are often overexpressed in tumors.
What experimental models are used to study this process?
Common models include CRISPR knockout and knock-in cell lines, live-cell imaging, adhesion assays, and proteomics.
What is the role of RhoA in cell-matrix adhesion?
RhoA regulates cytoskeletal tension and focal adhesion dynamics, and its activity can either promote or inhibit adhesion depending on context.
How do MMPs and TIMPs affect cell-matrix adhesion?
MMPs degrade ECM components to reduce adhesion, while TIMPs inhibit MMPs and stabilize adhesion.
Can CRISPR be used to study negative regulation of cell-matrix adhesion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What diseases are associated with dysregulated cell-matrix adhesion?
Cancer, fibrosis, and inflammatory disorders are linked to abnormal regulation of cell-matrix adhesion.
How can I measure negative regulation of cell-matrix adhesion in the lab?
Adhesion assays, live-cell imaging of focal adhesions, and biochemical analysis of signaling proteins are standard methods.
Conclusion
Negative regulation of cell-matrix adhesion (GO:0001953) is a critical biological process that controls cell detachment from the ECM, influencing development, tissue homeostasis, and disease. Key regulators such as Rho GTPases, ILK, FAK, and MMPs provide promising targets for therapeutic intervention. Advances in CRISPR-based models and imaging techniques continue to unravel the complexities of this process, offering new opportunities for drug discovery and personalized medicine.
References
- 1. Jeyabal PV et al.. 2014. Regulation of cell-matrix adhesion by OLA1, the Obg-like ATPase 1.. Biochem Biophys Res Commun 444(4):568-74 PMID: 24486488
- 2. Arthur WT et al.. 2002. Regulation of Rho family GTPases by cell-cell and cell-matrix adhesion.. Biol Res 35(2):239-46 PMID: 12415742
- 3. Boulter E et al.. 2006. Regulation of cell-matrix adhesion dynamics and Rac-1 by integrin linked kinase.. FASEB J 20(9):1489-91 PMID: 16723384
- 4. Sreenivasappa H et al.. 2014. Selective regulation of cytoskeletal tension and cell-matrix adhesion by RhoA and Src.. Integr Biol (Camb) 6(8):743-54 PMID: 24984203
- 5. Turner CE. 2000. Paxillin interactions.. J Cell Sci 113 Pt 23:4139-40 PMID: 11069756
- 6. Bourboulia D et al.. 2010. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.. Semin Cancer Biol 20(3):161-8 PMID: 20470890
- 7. Chen Z et al.. 2011. Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation.. Cell Signal 23(8):1404-12 PMID: 21511030
- 8. Cohen LA et al.. 2005. Mechanisms of focal adhesion kinase regulation.. Curr Cancer Drug Targets 5(8):629-43 PMID: 16375667
